Last reviewed · How we verify
NCT07317765
Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention
NA trial testing Natural Psychotherapy in Breast Cancer in 200 participants. Participants enrolled and being followed up; not accepting new ones.
30 December 2025
Quick facts
| Lead sponsor | Beijing HuiLongGuan Hospital |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 17 March 2025 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Natural Psychotherapy
- Receive routine psychotherapy and read popular science materials related to breast cancer.
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Beijing HuiLongGuan Hospital
Who can join
Adults 18 to 59, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Randomized Controlled Trial of Natural Psychotherapy for Intervening Negative Emotions in 100 Breast Cancer Patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07317765
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Natural Psychotherapy
Trials testing the same drug.
- NCT05552014 — Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis · NA · recruiting
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Beijing HuiLongGuan Hospital trials
Trials by the same sponsor.
- NCT07518264 — Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder · NA · active not recruiting
- NCT06292156 — tACS Treatment for Cognitive Impairments in Methamphetamine Addicts · NA · completed
- NCT05552014 — Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis · NA · recruiting
- NCT04055181 — Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders · NA · completed
- NCT05258123 — Ginkgo Biloba Extract in the Treatment of Schizophrenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07317765 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing HuiLongGuan Hospital
- Last refreshed: 5 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07317765.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing